Literature DB >> 19438500

Bone marrow cells from patients with Shwachman-Diamond syndrome abnormally express genes involved in ribosome biogenesis and RNA processing.

Piya Rujkijyanont1, Sally-Lin Adams, Joseph Beyene, Yigal Dror.   

Abstract

Shwachman-Diamond Syndrome (SDS) is a multi-system genetic disorder with bone marrow failure. SBDS, the gene associated with SDS, has been postulated to play a role in ribosome biogenesis and RNA processing, but its functions are still unknown. To study whether these pathways are interrupted when Sbds protein is lost, we studied the expression of related genes in patient SBDS-/- cells by an oligonucleotide microarray. We first analysed ribosomal protein (RP) genes, which are normally co-regulated. In SDS, 27 of the 85 RP genes were downregulated. Among the downregulated RP genes, seven are known to be associated with the inhibition of apoptosis. RPS27L, which mediates p53-dependent induction of apoptosis, was the only upregulated RP gene. Interestingly, several genes involved in RP mRNA transcription were downregulated without affecting the expression of genes involved in mRNA degradation, suggesting that the downregulation of the RP gene expression might be at the transcriptional level. Importantly we also found dysregulation of multiple genes involved in rRNA transcription and pre-rRNA processing. We conclude that SDS marrow cells exhibit major dysregulation of RP, RNA processing and RNA transcription genes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19438500     DOI: 10.1111/j.1365-2141.2009.07692.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  21 in total

Review 1.  When ribosomes go bad: diseases of ribosome biogenesis.

Authors:  Emily F Freed; Franziska Bleichert; Laura M Dutca; Susan J Baserga
Journal:  Mol Biosyst       Date:  2010-01-11

2.  Ribosomal biogenesis genes play an essential and p53-independent role in zebrafish pancreas development.

Authors:  Elayne Provost; Karen A Wehner; Xiangang Zhong; Foram Ashar; Elizabeth Nguyen; Rachel Green; Michael J Parsons; Steven D Leach
Journal:  Development       Date:  2012-09       Impact factor: 6.868

Review 3.  Ribosomopathies: human disorders of ribosome dysfunction.

Authors:  Anupama Narla; Benjamin L Ebert
Journal:  Blood       Date:  2010-03-01       Impact factor: 22.113

Review 4.  Ribosomal proteins and human diseases: pathogenesis, molecular mechanisms, and therapeutic implications.

Authors:  Wei Wang; Subhasree Nag; Xu Zhang; Ming-Hai Wang; Hui Wang; Jianwei Zhou; Ruiwen Zhang
Journal:  Med Res Rev       Date:  2014-08-28       Impact factor: 12.944

Review 5.  Clinical spectrum and molecular pathophysiology of Shwachman-Diamond syndrome.

Authors:  James N Huang; Akiko Shimamura
Journal:  Curr Opin Hematol       Date:  2011-01       Impact factor: 3.284

Review 6.  Ribosome biogenesis in skeletal development and the pathogenesis of skeletal disorders.

Authors:  Paul A Trainor; Amy E Merrill
Journal:  Biochim Biophys Acta       Date:  2013-11-16

Review 7.  Non-Diamond Blackfan anemia disorders of ribosome function: Shwachman Diamond syndrome and 5q- syndrome.

Authors:  Nicholas Burwick; Akiko Shimamura; Johnson M Liu
Journal:  Semin Hematol       Date:  2011-04       Impact factor: 3.851

Review 8.  Pathophysiology and management of inherited bone marrow failure syndromes.

Authors:  Akiko Shimamura; Blanche P Alter
Journal:  Blood Rev       Date:  2010-04-24       Impact factor: 8.250

9.  Clinical experience in T cell deficient patients.

Authors:  Theresa S Cole; Andrew J Cant
Journal:  Allergy Asthma Clin Immunol       Date:  2010-05-13       Impact factor: 3.406

10.  Repolarization of HSC attenuates HSCs failure in Shwachman-Diamond syndrome.

Authors:  Hartmut Geiger; Kasiani C Myers; Sachin Kumar; Kalpana J Nattamai; Aishlin Hassan; Amanda Amoah; Rebekah Karns; Cuiping Zhang; Ying Liang; Akiko Shimamura; M Carolina Florian; Ute Bissels; Martha Luevano; Andreas Bosio; Stella M Davies; Medhanie Mulaw
Journal:  Leukemia       Date:  2020-10-19       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.